(Total Views: 232)
Posted On: 01/24/2023 8:36:29 AM
Post# of 630
$HALB Halberd Agrees to Animal Testing at Mississippi State University
https://www.accesswire.com/736412/halberd-agr...university
College of Veterinary Medicine to conduct testing
JACKSON CENTER, PA / ACCESSWIRE / January 24, 2023 / Halberd Corporation's (OTC PINK:HALB) has agreed to conduct animal testing at Mississippi State University's (MSU) animal testing laboratory.
The Department of Comparative Biomedical Sciences in the College of Veterinary Medicine and the Department of Biomedical Engineering at Mississippi State University will be working with Halberd Corporation on an upcoming research project. The project will be investigating the effectiveness of novel therapeutic measures that are under development for combating the damaging effects of traumatic brain injury.
Dr. Russell Carr in the College of Veterinary Medicine stated, "My colleagues and I at the University are excited about the potential that the outcomes will have and the opportunity to collaborate with the Halberd Corporation."
Details on scope and timing to follow
https://www.accesswire.com/736412/halberd-agr...university
College of Veterinary Medicine to conduct testing
JACKSON CENTER, PA / ACCESSWIRE / January 24, 2023 / Halberd Corporation's (OTC PINK:HALB) has agreed to conduct animal testing at Mississippi State University's (MSU) animal testing laboratory.
The Department of Comparative Biomedical Sciences in the College of Veterinary Medicine and the Department of Biomedical Engineering at Mississippi State University will be working with Halberd Corporation on an upcoming research project. The project will be investigating the effectiveness of novel therapeutic measures that are under development for combating the damaging effects of traumatic brain injury.
Dr. Russell Carr in the College of Veterinary Medicine stated, "My colleagues and I at the University are excited about the potential that the outcomes will have and the opportunity to collaborate with the Halberd Corporation."
Details on scope and timing to follow
(0)
(0)
